Open AccessSTI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1
Author(s) -
Tengchuan Jin,
Hajime Nakatani,
Takahiro Taguchi,
Takumi Nakano,
Takehiro Okabayashi,
Takeki Sugimoto,
Mariko Kobayashi,
Keijiro Araki
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i5.703
Subject(s) - stromal cell , gist , microbiology and biotechnology , viability assay , mtt assay , cancer research , vascular endothelial growth factor , flow cytometry , stem cell factor , cell culture , biology , cell growth , imatinib mesylate , vascular endothelial growth factor a , chemistry , imatinib , stem cell , vegf receptors , haematopoiesis , biochemistry , myeloid leukemia , genetics
To estimate whether STI571 inhibits the expression of vascular endothelial growth factor (VEGF) in the gastrointestinal stromal tumor (GIST) cells.